ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Syndrome

COVID-19 trials near Hanyang, Seoul, KOR:

Immunogenicity and Safety of AdCLD-CoV19-1 OMI as a Booster: A COVID-19 Preventive Vaccine in Healthy Volunteers (COVID-19)

The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/dose/Vial) administered as a booster in healthy adults aged 19 years old a...

Enrolling
COVID-19
Vaccines
Biological: Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
Biological: AdCLD-CoV19-1 OMI

Phase 3

Cellid

Seoul, Korea, Republic of and 16 other locations

legal age for adult in each country) with confirmed mild or moderate COVID-19 tested positive with a real time reverse transcriptio...

Enrolling
COVID-19
Drug: ES16001 80 mg
Drug: ES16001 40 mg

Phase 2, Phase 3

Genencell

Seoul, Korea, Republic of and 2 other locations

Parallel-treatment Group, Adaptive Design, Multi-center, Phase 2b/3 Trial to Evaluate Efficacy and Safety of NuSepin® Intravenous Infusion in COVID...

Enrolling
COVID-19 Pneumonia
Drug: Placebo
Drug: NuSepin® 0.2 mg/kg

Phase 2, Phase 3

Shaperon

Incheon, Namdong-gu, Korea, Republic of

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Seoul, Korea, Republic of and 214 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Seoul, Gyeonggi-do, Korea, Republic of and 59 other locations

This clinical trial will evaluate the safety, tolerability and immunogenicity of GLS-5310 DNA vaccine against SARS-CoV-2(COVID-19) ...

Active, not recruiting
SARS-CoV-2
Biological: GLS-5310
Biological: Placebo

Phase 1, Phase 2

GeneOne Life Science

Seoul, Korea, Republic of

This clinical trial will evaluate the safety, tolerability and efficacy of GLS-1027 in the prevention of severe pneumonitis caused by SARS-CoV-2 infe...

Active, not recruiting
Pneumonitis
SARS-CoV Infection
Drug: GLS-1027
Drug: Placebo

Phase 2

GeneOne Life Science

Seoul, Korea, Republic of and 16 other locations

This study is to evaluate the safety, reactogenicity, and immunogenicity of the QTP104 vaccine against SARS-CoV-2 infection in healthy adults.

Active, not recruiting
COVID-19
SARS-CoV-2
Biological: QTP104 1ug
Biological: QTP104 5ug

Phase 1

Quratis

Seoul, Korea, Republic of and 1 other location

A dose-escalation, double-blinded, randomized, placebo-controlled phase 1 study to assess the safety, reactogenicity, and immunogenicity of a SARS-Co...

Enrolling
COVID-19 Vaccine Adverse Reaction
COVID-19 Infection
Biological: Placebo
Biological: LEM-mR203

Phase 1

Lemonex

Seoul, Korea, Republic of

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo
Drug: Lecanemab

Phase 3

Eisai
Eisai

Seoul, Korea, Republic of and 246 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems